University of Strathclyde spin-out Cutitronics has secured a major funding boost from FTSE 100 company Croda International.
The company, which was founded in 2014 by Dr David Heath, who was addressing a gap in the market for “personalised, adaptive skin care” which would, in their words, harness “the power of engineering and technology based innovation to support consumers in achieving their desired skincare and beauty results.”
Dr David Heath, Founder and Chief Executive Officer of Cutitronics said: “This milestone is the culmination of a process began three years ago, to validate CutiTron technically and commercially. We’re excited to be recognised by Croda and to now be partnering with them. The support from the team at Croda will be invaluable to us as we seek to develop our CutiTron technology, and grow our own team.”
Greater consumer insight
Sandra Breene, President of Personal Care & North America at Croda will join the Cutitronics Board as a part-time Non-Executive officer.
She said: “I am delighted to be personally involved in this partnership, which will not only allow us at Croda to be part of this intelligent application platform, but it will also enable us to utilise the very latest digital technology to gain greater insight of consumer behaviour.”
Support from Scottish Enterprise
Cutitronics also received support from Scottish Enterprise’s High Growth Ventures team in the form of a High Growth Adviser, internationalisation advice, product development, and business support.
Silvio Clemente, Scottish Enterprise Head of Company Growth – High Growth Ventures, said: “We have supported this highly ambitious and innovative company with services that have allowed them to become a viable business with the capability to make strategic partnerships and to trade internationally. We look forward to working closely with Cutitronics as it continues to innovate, to help it realise its growth potential.”